Efficacy And Safety Of Mil60, A Bevacizumab Biosimilar, In Combination With Paclitaxel/Carboplatin In Patients With Advanced Or Recurrent Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Multicenter Phase Iii Study

ANNALS OF ONCOLOGY(2021)

引用 0|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要